ISCHUA — The Cattaraugus County Sheriff’s Office reported Thursday it is searching for a man last seen April 10 in Olean. Deputies reported that as of ...

The scientists showed that, right at the onset of mild illness, the body also produces special T cells previously known only from chronic, severe infections and tumors. Even in the case of ...

However, age-related shifts in NK cell subpopulations provide a basis for hypothesizing potential mechanisms linking Immunosenescence to MS pathophysiology. Age-associated declines in perforin ...

The GI Cancers Symposium revealed new therapies for specific cancer subsets and progress in chimeric antigen receptor T-cell therapies for ... for the target itself and the expression profile in ...

Macroporous alginate scaffolds embedded with interleukin (IL)-2 and activating CD3/CD28 antibodies are used to transduce fresh T cells with lentiviral CAR constructs. CAR-T cells containing scaffolds ...

Following a successful Type B end-of-phase 2 meeting, the FDA has approved the start of a phase 3 trial of linperlisib in peripheral T-cell lymphoma. The FDA has granted clearance to initiate a global ...

While chimeric antigen receptor (CAR) T cell therapy is an essential therapeutic option for prolonging survival in patients with relapsed or refractory non-Hodgkin lymphomas (NHL), profound immune ...